trans-Hydroxy praziquantel
CAS: 134924-71-3
Ref. 3D-FH24096
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen | ||
| 100mg | Nachfragen |
Produktinformation
- 1,2,3,6,7,11b-Hexahydro-2-[(cis-4-hydroxycyclohexyl)carbonyl]-4H-pyrazino[2,1-a]isoquinolin-4-onetrans-1,2,3,6,7,11b-Hexahydro-2-[( 4-hydroxycyclohexyl)carbonyl]- 4H-pyrazino[2,1-a]isoquinolin-4-one
- 1,2,3,6,7,11b-Hexahydro-2-[(trans-4-hydroxycyclohexyl)carbonyl]-4H-pyrazino[2,1-a]isoquinolin-4-one
- 4H-Pyrazino(2,1-a)isoquinolin-4-one, 1,2,3,6,7,11b-hexahydro-2-((4-hydroxycyclohexyl)carbonyl)-
- 4H-Pyrazino[2,1-a]isoquinolin-4-one, 1,2,3,6,7,11b-hexahydro-2-[(4-hydroxycyclohexyl)carbonyl]-, trans-
- 4H-Pyrazino[2,1-a]isoquinolin-4-one, 1,2,3,6,7,11b-hexahydro-2-[(trans-4-hydroxycyclohexyl)carbonyl]-
Trans-hydroxypraziquantel is an anthelmintic drug that belongs to the group of quinolones. It is a racemate consisting of two enantiomers, which are mirror images of each other. Trans-hydroxypraziquantel has been used to treat schistosomiasis and other parasitic infections, as well as some forms of cancer. The pharmacologic properties of trans-hydroxypraziquantel are due to its uptake by the intestinal tract and subsequent metabolism in the liver, which results in a high plasma concentration. Trans-hydroxypraziquantel has been shown to be effective against various species of parasites and worms, including Schistosoma mansoni and Ascaris lumbricoides. This molecule binds to the parasite's plasma membrane by means of its hydrophobic properties, thus inhibiting phospholipid synthesis.
Chemische Eigenschaften
Technische Anfrage zu: 3D-FH24096 trans-Hydroxy praziquantel
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
